Treg cell-based therapies: challenges and perspectives von Raffin, Caroline, Vo, Linda T., Bluestone, Jeffrey A.

Volltext

CD28 Costimulation: From Mechanism to Therapy von Esensten, Jonathan H., Helou, Ynes A., Chopra, Gaurav, Weiss, Arthur, Bluestone, Jeffrey A.

Volltext

Is autoimmunity the Achilles' heel of cancer immunotherapy? von June, Carl H, Warshauer, Jeremy T, Bluestone, Jeffrey A

Volltext

Immunotherapy: Building a bridge to a cure for type 1 diabetes von Bluestone, Jeffrey A, Buckner, Jane H, Herold, Kevan C

Volltext

Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines von Kang, Jee Hye, Bluestone, Jeffrey A., Young, Arabella

Volltext

Genetics, pathogenesis and clinical interventions in type 1 diabetes von Bluestone, Jeffrey A., Herold, Kevan, Eisenbarth, George

Volltext

Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges von Sneddon, Julie B., Tang, Qizhi, Stock, Peter, Bluestone, Jeffrey A., Roy, Shuvo, Desai, Tejal, Hebrok, Matthias

Volltext

The Balancing Act between Cancer Immunity and Autoimmunity in Response to Immunotherapy von Young, Arabella, Quandt, Zoe, Bluestone, Jeffrey A

Volltext

Peripherally induced tregs - role in immune homeostasis and autoimmunity von Yadav, Mahesh, Stephan, Stephen, Bluestone, Jeffrey A

Volltext

Self-antigen-Driven Activation Induces Instability of Regulatory T Cells during an Inflammatory Autoimmune Response von Bailey-Bucktrout, Samantha L., Martinez-Llordella, Marc, Zhou, Xuyu, Anthony, Bryan, Rosenthal, Wendy, Luche, Herve, Fehling, Hans J., Bluestone, Jeffrey A.

Volltext

Regulatory T-cell therapy in transplantation: moving to the clinic von Tang, Qizhi, Bluestone, Jeffrey A

Volltext

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins von Schumann, Kathrin, Lin, Steven, Boyer, Eric, Simeonov, Dimitre R., Subramaniam, Meena, Gate, Rachel E., Haliburton, Genevieve E., Ye, Chun J., Bluestone, Jeffrey A., Doudna, Jennifer A., Marson, Alexander

Volltext

The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation von DuPage, Michel, Chopra, Gaurav, Quiros, Jason, Rosenthal, Wendy L, Morar, Malika M, Holohan, Dan, Zhang, Ruan, Turka, Laurence, Marson, Alexander, Bluestone, Jeffrey A

Volltext

The NOD mouse: a model of immune dysregulation von Anderson, Mark S, Bluestone, Jeffrey A

Volltext

CD3-specific antibodies: a portal to the treatment of autoimmunity von Chatenoud, Lucienne, Bluestone, Jeffrey A.

Volltext

Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency von Nguyen, David N., Roth, Theodore L., Li, P. Jonathan, Chen, Peixin Amy, Apathy, Ryan, Mamedov, Murad R., Vo, Linda T., Tobin, Victoria R., Goodman, Daniel, Shifrut, Eric, Bluestone, Jeffrey A., Puck, Jennifer M., Szoka, Francis C., Marson, Alexander

Volltext

Opportunities for Treg cell therapy for the treatment of human disease von Bluestone, Jeffrey A, McKenzie, Brent S, Beilke, Joshua, Ramsdell, Fred

Volltext

Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation von Molofsky, Ari B., Van Gool, Frédéric, Liang, Hong-Erh, Van Dyken, Steven J., Nussbaum, Jesse C., Lee, Jinwoo, Bluestone, Jeffrey A., Locksley, Richard M.

Volltext

Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity von Wang, David, Quiros, Jason, Mahuron, Kelly, Pai, Chien-Chun, Ranzani, Valeria, Young, Arabella, Silveria, Stephanie, Harwin, Tory, Abnousian, Arbi, Pagani, Massimiliano, Rosenblum, Michael D., Van Gool, Frederic, Fong, Lawrence, Bluestone, Jeffrey A., DuPage, Michel

Volltext

COMPLEXITIES OF CD28/B7: CTLA-4 COSTIMULATORY PATHWAYS IN AUTOIMMUNITY AND TRANSPLANTATION von Salomon, Benoît, Bluestone, Jeffrey A

Volltext